Eterna Therapeutics Inc
NASDAQ:ERNA

Watchlist Manager
Eterna Therapeutics Inc Logo
Eterna Therapeutics Inc
NASDAQ:ERNA
Watchlist
Price: 1.31 USD 3.97% Market Closed
Market Cap: 10.3m USD

Wall Street
Price Targets

ERNA Price Targets Summary
Eterna Therapeutics Inc

There are no price targets for ERNA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Eterna Therapeutics Inc Competitors:
Price Targets
LCTX
Lineage Cell Therapeutics Inc
126% Upside
ABOS
Acumen Pharmaceuticals Inc
208% Upside
VLA
Valneva SE
102% Upside
EDT
Spectral Medical Inc
149% Upside
ACLX
Arcellx Inc
78% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
65% Upside
EDIT
Editas Medicine Inc
111% Upside
RCKT
Rocket Pharmaceuticals Inc
149% Upside

Revenue
Forecast

Revenue Estimate
Eterna Therapeutics Inc

For the last 13 years the compound annual growth rate for Eterna Therapeutics Inc's revenue is -25%.

-25%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eterna Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Eterna Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ERNA's stock price target?
Not Available

ERNA doesn't have any price targets made by Wall Street professionals.

Back to Top